PubMed · 14580577
Enabling inverse metabolic engineering through genomics.
Abstract
Inverse metabolic engineering (IME) is a powerful framework for engineering cellular phenotypes. Progress in this field has been limited by a lack of comprehensive methods for efficiently identifying the genetic basis of relevant phenotypes. Advances in genomics technologies, including DNA microarrays and gene sequencing, have dramatically improved our ability to relate changes in phenotype with associated changes in genotype. When applied in the context of IME, these tools should enable the integration of "evolutionary" and "direct" approaches to engineering cell physiology, which should improve our understanding of the complex interactions affecting the expression, evolution and engineering of traits in natural and industrial hosts.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Ryan T Gill. 2003. Enabling inverse metabolic engineering through genomics.. https://doi.org/10.1016/s0958-1669(03)00116-2. https://pubmed.health/record/pubmed%3A14580577/enabling-inverse-metabolic-engineering-through-genomics
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.